RNLX
$2.57
Renalytix Ai Plc ADR
($.01)
(.39%)
RNLX
Earnings Whisper ®
N/A
4th Quarter June 2022
Consensus:  ($0.17)
Revenue:  $0.81 Mil
Thursday
Sep 29
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when RNLX reports earnings?
Beat
Meet
Miss

Where is RNLX's stock price going from here?
Up
Flat
Down
Stock chart of RNLX
Analysts
Summary of analysts' recommendations for RNLX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Renalytix AI plc is an artificial intelligence-enabled in vitro diagnostics company. It focuses on optimizing clinical management of kidney disease. Renalytix AI plc is based in NEW YORK.